Core Viewpoint - IQSTEL Inc. is set to host an investor conference call on April 7, 2026, to discuss its financial results for Q4 2025 and the full year, highlighting its strategic expansion into the Digital Health market as a new high-growth vertical [1][2][5]. Financial Performance - The company will review its financial performance during the call, providing insights into its revenue growth and the underlying value of its business platform [3][4]. - IQSTEL reported preliminary revenue of approximately $317 million for FY 2025, indicating strong commercial traction and record quarterly revenue [15]. Strategic Expansion - IQSTEL is entering the Digital Health market, which is a multi-billion-dollar global opportunity, leveraging its telecom platform to deliver technology-driven healthcare services [5][8]. - The company aims to capitalize on trends such as aging populations, rising healthcare costs, and the rapid adoption of connected devices [7][8]. Business Platform - IQSTEL has established a scalable commercial platform that connects with over 600 of the largest telecom operators globally, facilitating efficient revenue generation and service expansion [4][9]. - The platform is viewed as a strategic asset that supports revenue growth and margin expansion, enabling the rollout of new high-tech service offerings [4][9]. Management Commentary - CEO Leandro Jose Iglesias emphasized the company's roadmap towards achieving $1 billion in revenue, driven by the expansion of high-tech, high-margin services [9][10]. - Management is optimistic about the Digital Health market's potential and plans to share more details during the upcoming earnings call [10].

Core Viewpoint - The article discusses the growing interest in cheap stocks as investors seek to avoid high valuations in equity markets, highlighting a shift towards value stocks that have underperformed in recent years and are showing signs of recovery [1]. Group 1: Market Trends - The iShares Russell 1000 Value ETF increased by 3.9% in the fourth quarter, while the iShares Russell 1000 Growth ETF gained only 2.3%, indicating a renewed focus on value stocks [2]. - The S&P 500 is expected to continue its double-digit rallies, but future gains may be more challenging, with a potential shift towards value stocks as the Federal Reserve may cut interest rates [2]. - Dennis DeBusschere, chief market strategist at 22V Research, noted that productivity improvements could allow the economy to grow at 2.5% without inflation issues, benefiting fundamental factors and procyclical equities [3]. Group 2: Investment Methodology - The methodology for identifying the best cheap stocks involved selecting U.S.-listed stocks with a price-to-earnings (P/E) ratio of less than 15 and an upside potential of over 60% as of January 16, focusing on those popular among elite hedge funds [6]. - The strategy of imitating top stock picks from hedge funds has historically outperformed the market, with a quarterly newsletter returning 427.7% since May 2014, surpassing its benchmark by 264 percentage points [8]. Group 3: Company Highlights - VEON Ltd. (NASDAQ:VEON) has a forward P/E of 13.77 and an upside potential of 60.23%, with 12 hedge fund holders. The company confirmed that its subsidiary Kyivstar has over 3 million registered users for satellite connectivity in Ukraine [9][10]. - Playtika Holding Corp. (NASDAQ:PLTK) has a forward P/E of 6.98 and an upside potential of 105.13%, with 27 hedge fund holders. The company announced a cost-cutting initiative, laying off 15% of its workforce to transition to leaner teams utilizing AI and automation [16][17].